In Vivo Efficacy of Anti-CD20-Interferon-Gamma Fusion Protein Against Syngeneic B Cell Lymphoma Is Mediated By Natural Killer Cells

被引：0
|
作者：
Vasuthasawat, Alex [1 ]
Yamada, Reiko E. [2 ]
Trinh, Kham R. [1 ]
Rokni, Neiki [2 ]
Morrison, Sherie L. [1 ]
Timmerman, John M. [2 ]
机构：
[1] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA USA
[2] Univ Calif Los Angeles, Div Hematol Oncol, Los Angeles, CA USA
来源：
BLOOD | 2019年 / 134卷
关键词：
D O I：
10.1182/blood-2019-131890
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1575
引用
收藏
页数：3
相关论文
共 50 条
  • [1] Anti-CD20-Interferon-β Fusion Protein Therapy of Murine B-Cell Lymphomas
    Trinh, Kham R.
    Vasuthasawat, Alex
    Steward, Kristopher K.
    Yamada, Reiko E.
    Timmerman, John M.
    Morrison, Sherie L.
    JOURNAL OF IMMUNOTHERAPY, 2013, 36 (05) : 305 - 318
  • [2] In Vivo Eradication of a Rituximab-Resistant Human CD20+ B Cell Lymphoma by Rituximab-CpG Oligodeoxynucleotide Conjugate Is Mediated by Natural Killer Cells and Complement
    Betting, David J.
    Kafi, Kamran
    Yamada, Reiko E.
    Steward, Kristopher K.
    Olafsen, Tove
    Wu, Anna M.
    van Rooijen, Nico
    Timmerman, John M.
    BLOOD, 2009, 114 (22) : 302 - 302
  • [3] Targeted delivery of interferon alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
    Xuan, Caiyun
    Steward, Kristopher
    Timmerman, John
    Morrison, Sherie
    JOURNAL OF IMMUNOLOGY, 2010, 184
  • [4] Mechanistic systems pharmacology model of adaptive immune system activation in response to anti-CD20-interferon-β fusion protein in B cell Lymphoma
    Bazzazi, Hojjat
    Xia, Cindy
    Zhu, Andy
    JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS, 2018, 45 : S35 - S35
  • [5] Targeted delivery of interferon-alpha via fusion to anti-CD20 results in potent antitumor activity against B-cell lymphoma
    Xuan, Caiyun
    Steward, Kristopher K.
    Timmerman, John M.
    Morrison, Sherie L.
    BLOOD, 2010, 115 (14) : 2864 - 2871
  • [6] Ibrutinib plus anti-CD20-interferon alpha fusion protein for treatment of B cell lymphomas.
    Kendle, Ryan F.
    Kimaiyo, Davis Kipkemboi
    Yamada, Reiko E.
    Young, Patricia
    Vasuthasawat, Alex
    Trinh, Ryan K.
    Morrison, Sherie L.
    Timmerman, John
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [7] Anti-CD20 antibody-coated, irradiated autologous tumor cells provide protective immunity against B cell lymphoma in vivo
    Steward, Kristopher
    Timmerman, John
    CANCER RESEARCH, 2009, 69
  • [8] Efficacy of anti-CD20 chimeric Fab′ fragment on proliferation of B lymphoma cells
    Lai, ZZ
    Xiong, DS
    Fan, DM
    Xu, YF
    Liu, HZ
    Peng, H
    Zhu, ZP
    Yang, CZ
    CHINESE SCIENCE BULLETIN, 2001, 46 (14): : 1182 - 1186
  • [9] Efficacy of anti-CD20 chimeric Fab' fragment on proliferation of B lymphoma cells
    LAI Zengzu
    Science Bulletin, 2001, (14) : 1182 - 1186
  • [10] 89Zr-ImmunoPET Shows Therapeutic Efficacy of Anti-CD20-IFNα Fusion Protein in a Murine B-cell Lymphoma Model
    Zettlitz, Kirstin A.
    Salazar, Felix B.
    Yamada, Reiko E.
    Trinh, K. Ryan
    Vasuthasawat, Alex
    Timmerman, John M.
    Morrison, Sherie L.
    Wu, Anna M.
    MOLECULAR CANCER THERAPEUTICS, 2022, 21 (04) : 607 - 615
12345